JIIQARGO Trademark

Trademark Overview


On Thursday, July 25, 2019, a trademark application was filed for JIIQARGO with the United States Patent and Trademark Office. The USPTO has given the JIIQARGO trademark a serial number of 79270865. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by JCR Pharmaceuticals Co., Ltd.. The JIIQARGO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the treatment of peripheral nervous system disorders; pharmaceutical preparations for the treatment of growth deficiencies; pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of Fabry disease, Gaucher disease, GM1 Gangliosidosis, GM2 Gangliosidosis, Krabbe disease, Niemann-Pick disease, Metachromatic leukodystrophy, Hurier syndrome, Hunter disease, Sanfilippo syndrome, Morquio syndrome, Sly syndrome, Pompe disease, Alfa-mannosidosis disease, Fucosidosis disease, and Neuronal ceroid lipofuscinosis
jiiqargo

General Information


Serial Number79270865
Word MarkJIIQARGO
Filing DateThursday, July 25, 2019
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6171912
Registration DateTuesday, October 13, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the treatment of peripheral nervous system disorders; pharmaceutical preparations for the treatment of growth deficiencies; pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of Fabry disease, Gaucher disease, GM1 Gangliosidosis, GM2 Gangliosidosis, Krabbe disease, Niemann-Pick disease, Metachromatic leukodystrophy, Hurier syndrome, Hunter disease, Sanfilippo syndrome, Morquio syndrome, Sly syndrome, Pompe disease, Alfa-mannosidosis disease, Fucosidosis disease, and Neuronal ceroid lipofuscinosis
Translation of Words in MarkThe wording "JIIQARGO" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJCR Pharmaceuticals Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameJCR Pharmaceuticals Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameJCR Pharmaceuticals Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Saturday, February 20, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, January 30, 2021FINAL DISPOSITION NOTICE SENT TO IB
Saturday, January 30, 2021FINAL DISPOSITION PROCESSED
Wednesday, January 13, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 13, 2020REGISTERED-PRINCIPAL REGISTER
Friday, July 31, 2020NOTIFICATION PROCESSED BY IB
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 15, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 15, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 23, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 15, 2020ASSIGNED TO LIE
Friday, February 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 21, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 21, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 21, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 21, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 21, 2019REFUSAL PROCESSED BY IB
Saturday, November 30, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 30, 2019REFUSAL PROCESSED BY MPU
Tuesday, November 12, 2019APPLICATION FILING RECEIPT MAILED
Saturday, November 9, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, November 8, 2019NON-FINAL ACTION WRITTEN
Friday, November 8, 2019ASSIGNED TO EXAMINER
Friday, November 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 31, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB